Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome

Jiayu Wang, Xianwei Huang, Caihua Fu, Qiping Sheng, Ping Liu, Jiayu Wang, Xianwei Huang, Caihua Fu, Qiping Sheng, Ping Liu

Abstract

Background: Multivessel coronary disease (MVCD) is the common type of coronary artery disease in acute coronary syndrome (ACS). Coronary artery calcification (CAC) has been confirmed the strong predictor of major adverse cardiovascular events (MACEs). Several studies have validated that triglyceride glucose (TyG) index can reflect the degree of coronary calcification or predict MACEs. However, no evidence to date has elucidated and compared the predictive intensity of TyG index or/and coronary artery calcification score (CACS) on multi-vascular disease and MACEs in ACS patients.

Methods: A total of 935 patients, diagnosed with ACS and experienced coronary computed tomography angiography (CCTA) from August 2015 to March 2022 in the Second Hospital of Shandong University, were selected for retrospective analysis. The subjects were divided into TyG index quartile 1-4 groups (Q1-Q4 groups), non-multivessel coronary disease (non-MVCD) and multivessel coronary disease (MVCD) groups, respectively. The general data, past medical or medication history, laboratory indicators, cardiac color Doppler ultrasound, CACS, and TyG indexes were respectively compared among these groups. The ROC curve preliminarily calculated and analyzed the diagnostic value of TyG index, CACS, and the combination of the two indicators for MVCD. Univariate and multivariate logistic regression analysis discriminated the independent hazard factors for forecasting MVCD.

Results: Compared with the lower TyG index and non-MVCD groups, the higher TyG index and MVCD groups had higher values of age, smoking history, waist circumference, systolic blood pressure, low-density lipoprotein cholesterol(LDL-C), fasting blood glucose and glycosylated hemoglobin, and CACS, but lower values of high-density lipoprotein cholesterol(HDL-C) (all P < 0.01). Coronary artery calcification is more common in the left anterior descending artery. Compared with non-MVCD, each unit increase in TyG index was associated with a 1.213-fold increased risk of MVCD. Logistic regression analysis adjusted for potential confounders indicated that TyG index is an independent risk factor for MVCD. With the increase of TyG index, the incidence of MACEs, apart from all-cause death, cardiac death, unexpected re-hospitalization of heart failure, recurrent ACS or unplanned revascularization, and non-fatal stroke in coronary artery increased (P log-rank < 0.001).

Conclusion: TyG index could completely substitute for CACS as a reliable, practical, and independent indicator for predicting the severity and prognosis of MVCD in patients with ACS.

Trial registration: ClinicalTrials.gov NCT04026724.

Keywords: Acute coronary syndrome; Coronary artery calcification score; Coronary computed tomography angiography; Multivessel disease; Triglyceride glucose product index.

Conflict of interest statement

We declare that we have no conflict of interest..

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
CTA images of a 75 year old woman with severe coronary calcification and disease. Different coronary CTA three-dimensional reconstruction techniques were used: AD, VRT (volume rendering technique) for the whole myocardium and coronary arteries. EH, VRT for coronary vascular trees. IM, MIP (maximum intensity projections) for coronary vascular trees. NU, CPR (curved planner reconstruction) for the degree of coronary stenosis and calcification in each large coronary branch: right coronary artery (N and R); left anterior descending branch (O and S); left circumflex branch (P and T); left marginal branch (Q); first diagonal branch (U)
Fig. 2
Fig. 2
Comparison of coronary calcification scores in each quartile array of TyG index. vs. TyG index quartile 1 group. *P < 0.05, **P < 0.01; vs. TyG index quartile 2 group, #P < 0.05, ##P < 0.01; vs. TyG index quartile 3 group, ∆P < 0.05, ∆∆P < 0.01
Fig. 3
Fig. 3
Forest plot demonstrated clinical risk factors significantly affecting coronary calcification. The association between clinical risk factors and coronary calcification degree was displayed in the forest plot. OR, Odd Ratio; CI: confidence interval, all P < 0.05%. Adjusted for age, gender, AHD (antihypertensive drugs), HGD (Hypoglycemic drugs), LLD (lipid-lowering drugs), body weight, BMI(body mass index), WC (waist circumference), SBP (systolic blood pressure), DBP (diastolic blood pressure), PPD(pulse pressure difference), HR (heart rate), FBG (fasting blood glucose), HbA1c (glycosylated hemoglobin A1c), LVEF, diabetes, hypertension, hyperlipidemia, smoking, drinking, white blood cell, TC(total cholesterol), LDL-C (low-density lipoprotein), HDL-C (high-density lipoprotein), Cr (creatinine), UA (uric acid), Cys C (Cystatin C), homocysteine, D-dimer, TnI (troponin I), and BNP (B-type natriuretic peptide) except for the stratified variables
Fig. 4
Fig. 4
Forest plot displayed the clinical risk factors affecting the severity of coronary disease. Statistical methods and related abbreviations are the same as Fig. 3 (all P < 0.05%)
Fig. 5
Fig. 5
Comparison of CASC in each coronary branch between non-multivessel and multivessel disease groups. CASC, coronary calcification score; LM, left main artery; LAD, left anterior descending branch; LCX, left circumflex branch; RCA, right coronary artery. Coronary artery calcification score expressed as a categorical variable: CACS < 62.36 (median value); CACS ≥ 62.36. vs. non-multivessel group, *P < 0.05, **P < 0.01
Fig. 6
Fig. 6
Comparison of TyG indexes between non-MVCD and MVCD groups. TyG index, triglyceride-glucose index; non-MVCD, Non-multivessel coronary disease; MVCD, multivessel coronary disease. Non-multivessel disease was defined as at least 50% stenosis in one major coronary artery. Multivessel disease was defined as at least two major vessels (≥ 2 mm diameter) from different territories with lesions deemed angiographically significant (≥ 50% stenosis). vs. non-MVCD, *P < 0.05, **P < 0.01
Fig. 7
Fig. 7
ROC curve analysis of TyG index or/and CASC to predict coronary disease severity. TyG index, triglyceride-glucose index; CASC, coronary artery calcium score
Fig. 8
Fig. 8
Cumulative hazard function of different clinical endpoints according to TyG indexes. Kaplan–Meier curves demonstrated the cumulative hazard function of the primary endpoint (A), cardiovascular death (B), all-cause death (C), heart failure rehospitalization (D), Hospitalization for non-fatal myocardial infarction, angina and unplanned revascularization (E), and non-fatal stroke (F) among the 4 groups based on the TyG index quartiles. TyG index quartile 1 (Q1), 7.37–8.51; quartile 2 (Q2), 8.82–8.99; quartile 3 (Q3), 9.00–9.53; quartile 4 (Q4), 9.54–11.504. Except for the primary endpoint, the comparison of other clinical endpoints between Q1-Q4 groups reached significant differences (P < 0.05)

References

    1. Zhao X, Wang Y, Chen R, Li J, Zhou J, Liu C, Zhou P, Sheng Z, Chen Y, Song L, Zhao H, Yan H. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study. Cardiovasc Diabetol. 2021;20(1):131. doi: 10.1186/s12933-021-01321-7.
    1. Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18(1):150. doi: 10.1186/s12933-019-0957-3.
    1. Kurihara O, Takano M, Yamamoto E, Yonetsu T, Kakuta T, Soeda T, Yan BP, Crea F, Higuma T, Kimura S, Minami Y, Adriaenssens T, Boeder NF, Nef HM, Kim CJ, Thondapu V, Kim HO, Russo M, Sugiyama T, Fracassi F, Lee H, Mizuno K, Jang IK. Seasonal variations in the pathogenesis of acute coronary syndromes. J Am Heart Assoc. 2020;9(13):e015579. doi: 10.1161/JAHA.119.015579.
    1. Shiyovich A, Shlomo N, Cohen T, Iakobishvili Z, Kornowski R, Eisen A. Temporal trends of patients with acute coronary syndrome and multivessel coronary artery disease - from the ACSIS registry. Int J Cardiol. 2020;304:8–13. doi: 10.1016/j.ijcard.2020.01.040.
    1. Zaman MO, Mojadidi MK, Elgendy IY. Revascularization strategies for patients with myocardial infarction and multi-vessel disease: a critical appraisal of the current evidence. J Geriatr Cardiol. 2019;16(9):717–723.
    1. Mori H, Torii S, Kutyna M, Sakamoto A, Finn AV, Virmani R. Coronary artery calcification and its progression: what does it really mean? JACC Cardiovasc Imaging. 2018;11(1):127–142. doi: 10.1016/j.jcmg.2017.10.012.
    1. Nakahara T, Dweck MR, Narula N, Pisapia D, Narula J, Strauss HW. Coronary artery calcification: from mechanism to molecular imaging. JACC Cardiovasc Imaging. 2017;10(5):582–593. doi: 10.1016/j.jcmg.2017.03.005.
    1. Koulaouzidis G, Charisopoulou D, Jenkins PJ, Koulaouzidis A, McArthur T. Prevalence of non-calcified coronary plaque in patients with calcium score of 0: the silent enemy. Angiology. 2013;64(3):205–210. doi: 10.1177/0003319712440618.
    1. Koulaouzidis G, Charisopoulou D, Maffrett S, Tighe M, Jenkins PJ, McArthur T. Differences in clinical profile of individuals with severe and markedly elevated coronary artery calcification detected by electron beam computed tomography. Angiology. 2013;64(6):435–439. doi: 10.1177/0003319712454217.
    1. Henein MY, Koulaouzidis G, Granasen G, Wiklund U, Guerci A, Schmermund A. The natural history of coronary calcification: a meta-analysis from St Francis and EBEAT trials. Int J Cardiol. 2013;168(4):3944–3948. doi: 10.1016/j.ijcard.2013.06.057.
    1. Sugiyama T, Yamamoto E, Fracassi F, Lee H, Yonetsu T, Kakuta T, Soeda T, Saito Y, Yan BP, Kurihara O, Takano M, Niccoli G, Crea F, Higuma T, Kimura S, Minami Y, Ako J, Adriaenssens T, Boeder NF, Nef HM, Fujimoto JG, Fuster V, Finn AV, Falk E, Jang IK. Calcified plaques in patients with acute coronary syndromes. JACC Cardiovasc Interv. 2019;12(6):531–540. doi: 10.1016/j.jcin.2018.12.013.
    1. Patel J, Pallazola VA, Dudum R, Greenland P, McEvoy JW, Blumenthal RS, Virani SS, Miedema MD, Shea S, Yeboah J, Abbate A, Hundley WG, Karger AB, Tsai MY, Sathiyakumar V, Ogunmoroti O, Cushman M, Savji N, Liu K, Nasir K, Blaha MJ, Martin SS, Al RM. Assessment of coronary artery calcium scoring to guide statin therapy allocation according to risk-enhancing factors: the multi-ethnic study of atherosclerosis. JAMA Cardiol. 2021;6(10):1161–1170. doi: 10.1001/jamacardio.2021.2321.
    1. Won KB, Park EJ, Han D, Lee JH, Choi SY, Chun EJ, Park SH, Han HW, Sung J, Jung HO, Chang HJ. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol. 2020;19(1):34. doi: 10.1186/s12933-020-01008-5.
    1. Reith S, Milzi A, Lemma ED, Dettori R, Burgmaier K, Marx N, Burgmaier M. Intrinsic calcification angle: a novel feature of the vulnerable coronary plaque in patients with type 2 diabetes: an optical coherence tomography study. Cardiovasc Diabetol. 2019;18(1):122. doi: 10.1186/s12933-019-0926-x.
    1. Park K, Ahn CW, Lee SB, Kang S, Nam JS, Lee BK, Kim JH, Park JS. Elevated TyG Index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569–1573. doi: 10.2337/dc18-1920.
    1. Williams MC, Moss AJ, Dweck M, Adamson PD, Alam S, Hunter A, Shah ASV, Pawade T, Weir-McCall JR, Roditi G, van Beek EJR, Newby DE, Nicol ED. Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study. J Am Coll Cardiol. 2019;73(3):291–301. doi: 10.1016/j.jacc.2018.10.066.
    1. Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, Yang H, Ren LB, Qi W, Li WY, Zhang R, Xu JH. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80. doi: 10.1186/s12933-020-01054-z.
    1. Jiao Y, Su Y, Shen J, Hou X, Li Y, Wang J, Liu B, Qiu D, Sun Z, Chen Y, Xi Q, Shen M, Fu Z. Evaluation of the long-term prognostic ability of triglyceride-glucose index for elderly acute coronary syndrome patients: a cohort study. Cardiovasc Diabetol. 2022;21(1):3. doi: 10.1186/s12933-021-01443-y.
    1. Simental-Mendía LE, Ortega-Pacheco CJ, García-Guerrero E, Sicsik-Aragón MA, Guerrero-Romero F, Martínez-Aguilar G. The triglycerides and glucose index is strongly associated with hepatic steatosis in children with overweight or obesity. Eur J Pediatr. 2021;180(6):1755–1760. doi: 10.1007/s00431-021-03951-1.
    1. Ma X, Dong L, Shao Q, Cheng Y, Lv S, Sun Y, Shen H, Wang Z, Zhou Y, Liu X. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):31. doi: 10.1186/s12933-020-01006-7.
    1. Hu C, Zhang J, Liu J, Liu Y, Gao A, Zhu Y, Zhao Y. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1c in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China. Cardiovasc Diabetol. 2020;19(1):116. doi: 10.1186/s12933-020-01091-8.
    1. Park B, Lee HS, Lee YJ. Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the Korean Genome and Epidemiology Study cohort. Transl Res. 2021;228:42–51. doi: 10.1016/j.trsl.2020.08.003.
    1. Zheng Q, Jiang J, Huo Y, Chen D. Genetic predisposition to type 2 diabetes is associated with severity of coronary artery disease in patients with acute coronary syndromes. Cardiovasc Diabetol. 2019;18(1):131. doi: 10.1186/s12933-019-0930-1.
    1. Almendro-Delia M, Seoane García T, Villar Calle P, García González N, Lorenzo López B, Cortés FJ, García Del Río M, Ruiz García MDP, Hidalgo Urbano RJ, García-Rubira JC. Prevalence and clinical significance of totally occluded infarct-related arteries in patients with non-ST-segment elevation acute coronary syndromes. Int J Cardiol. 2021;324:1–7. doi: 10.1016/j.ijcard.2020.09.040.
    1. Luan H, Song Y, Cao L, Wang P, Zhu D, Tian G. Gender differences in the relationship of waist circumference to coronary artery lesions and one-year re-admission among coronary artery disease patients with normal body mass index. Diabetes Metab Syndr Obes. 2021;14:4097–4107. doi: 10.2147/DMSO.S330194.
    1. Yahagi K, Kolodgie FD, Lutter C, Mori H, Romero ME, Finn AV, Virmani R. Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus. Arterioscler Thromb Vasc Biol. 2017;37(2):191–204. doi: 10.1161/ATVBAHA.116.306256.
    1. Razavi AC, Wong N, Budoff M, Bazzano LA, Kelly TN, He J, Fernandez C, Lima J, Polak JF, Mongraw-Chaffin M, deFilippi C, Szklo M, Bertoni AG, Blumenthal RS, Blaha MJ, Whelton SP. Predicting long-term absence of coronary artery calcium in metabolic syndrome and diabetes: the MESA study. JACC Cardiovasc Imaging. 2021;14(1):219–229. doi: 10.1016/j.jcmg.2020.06.047.
    1. Björnsson E, Thorleifsson G, Helgadóttir A, Guðnason T, Guðbjartsson T, Andersen K, Grétarsdóttir S, Ólafsson Í, Tragante V, Ólafsson ÓH, Jónsdóttir B, Eyjólfsson GI, Sigurðardóttir Ó, Thorgeirsson G, Guðbjartsson DF, Thorsteinsdóttir U, Hólm H, Stefánsson K. Association of genetically predicted lipid levels with the extent of coronary atherosclerosis in icelandic adults. JAMA Cardiol. 2020;5(1):13–20. doi: 10.1001/jamacardio.2019.2946.
    1. Hirata A, Kakino A, Okamura T, Usami Y, Fujita Y, Kadota A, Fujiyoshi A, Hisamatsu T, Kondo K, Segawa H, Sawamura T, Miura K, Ueshima H, SESSA Research Group The relationship between serum levels of LOX-1 ligand containing ApoAI as a novel marker of dysfunctional HDL and coronary artery calcification in middle-aged Japanese men. Atherosclerosis. 2020;313:20–25. doi: 10.1016/j.atherosclerosis.2020.09.013.
    1. Lee MJ, Park JT, Chang TI, Joo YS, Yoo TH, Park SK, Chung W, Kim YS, Kim SW, Oh KH, Kang SW, Choi KH, Ahn C, Han SH. Smoking cessation and coronary artery calcification in CKD. Clin J Am Soc Nephrol. 2021;16(6):870–879. doi: 10.2215/CJN.15751020.
    1. Oshunbade AA, Kassahun-Yimer W, Valle KA, Hamid A, Kipchumba RK, Kamimura D, Clark D, 3rd, White WB, DeFilippis AP, Blaha MJ, Benjamin EJ, O'Brien EC, Mentz RJ, Rodriguez CJ, Fox ER, Butler J, Keith RJ, Bhatnagar A, Marie Robertson R, Correa A, Hall ME. Cigarette smoking, incident coronary heart disease, and coronary artery calcification in black adults: the Jackson heart study. J Am Heart Assoc. 2021;10(7):e017320. doi: 10.1161/JAHA.120.017320.
    1. Wu H, Du Q, Dai Q, Ge J, Cheng X. Cysteine protease cathepsins in atherosclerotic cardiovascular diseases. J Atheroscler Thromb. 2018;25(2):111–123. doi: 10.5551/jat.RV17016.
    1. Bundy JD, Chen J, Yang W, Budoff M, Go AS, Grunwald JE, Kallem RR, Post WS, Reilly MP, Ricardo AC, Rosas SE, Zhang X, He J, CRIC Study Investigators Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: the CRIC study. Atherosclerosis. 2018;271:53–60. doi: 10.1016/j.atherosclerosis.2018.02.009.
    1. Bittner DO, Mayrhofer T, Bamberg F, et al. Impact of coronary calcification on clinical management in patients with acute chest pain. Circ Cardiovasc Imaging. 2017;10(5):e005893. doi: 10.1161/CIRCIMAGING.116.005893.
    1. Lee EY, Yang HK, Lee J, et al. Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes. Lipids Health Dis. 2016;15(1):155. doi: 10.1186/s12944-016-0324-2.
    1. Thai PV, Tien HA, Van Minh H, et al. Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2020;19(1):137. doi: 10.1186/s12933-020-01108-2.
    1. Park GM, Cho YR, Won KB, Yang YJ, Park S, Ann SH, Kim YG, Park EJ, Kim SJ, Lee SG, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee SW, Kim YH. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors. Lipids Health Dis. 2020;19(1):7. doi: 10.1186/s12944-020-1187-0.

Source: PubMed

3
Abonnieren